David E Kleiner Selected Research

Aspartate Aminotransferases (Aspartate Transaminase)

1/2021	Hepatic Steatosis and Steatohepatitis in a Large North American Cohort of Adults With Chronic Hepatitis B.
1/2020	Vibration-controlled transient elastography for the detection of cirrhosis in chronic hepatitis D infection.
1/2020	Evaluating Noninvasive Markers to Identify Advanced Fibrosis by Liver Biopsy in HBV/HIV Co-infected Adults.
1/2020	Hepatic Histology in Treatment-naïve Children With Chronic Hepatitis B Infection Living in the United States and Canada.
10/2019	Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease.
1/2018	Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis.
1/2018	Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B.
12/2016	In Children With Nonalcoholic Fatty Liver Disease, Cysteamine Bitartrate Delayed Release Improves Liver Enzymes but Does Not Reduce Disease Activity Scores.
11/2013	Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients.
3/2013	Discordance among transient elastography, aspartate aminotransferase to platelet ratio index, and histologic assessments of liver fibrosis in patients with chronic hepatitis C.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David E Kleiner Research Topics

Disease

72	Fibrosis (Cirrhosis) 05/2022 - 01/2003
50	Non-alcoholic Fatty Liver Disease 10/2022 - 01/2004
37	Inflammation (Inflammations) 11/2021 - 01/2003
32	Liver Diseases (Liver Disease) 04/2022 - 01/2003
31	Neoplasms (Cancer) 11/2022 - 05/2002
28	Infections 04/2022 - 02/2003
21	Chemical and Drug Induced Liver Injury 04/2022 - 06/2011
13	Hepatocellular Carcinoma (Hepatoma) 12/2021 - 10/2010
13	Chronic Hepatitis C 03/2015 - 02/2003
12	Fatty Liver 10/2022 - 02/2005
10	Insulin Resistance 01/2021 - 01/2004
9	Disease Progression 11/2022 - 02/2003
9	Hepatitis B 10/2022 - 10/2009
9	Acute Liver Failure (Fulminant Hepatic Failure) 10/2021 - 06/2012
9	Hepatitis 01/2021 - 08/2012
9	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 01/2003
8	Coinfection 10/2022 - 01/2013
8	Hepatitis C 01/2020 - 02/2003
7	HIV Infections (HIV Infection) 01/2021 - 03/2015
5	Portal Hypertension 04/2022 - 10/2011
5	Alcoholic Fatty Liver 01/2022 - 01/2009
5	Hypertension (High Blood Pressure) 11/2021 - 08/2006
5	Chronic Hepatitis B 01/2021 - 05/2009
5	Body Weight (Weight, Body) 01/2021 - 04/2006
5	Hypoxia (Hypoxemia) 10/2019 - 07/2006
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 03/2011
4	Autoimmune Hepatitis 01/2021 - 05/2009
4	Necrosis 01/2018 - 01/2003
4	Cholestasis 11/2017 - 01/2013
3	Cholangiocarcinoma 12/2021 - 10/2010
3	Hyperlipidemias (Hyperlipidemia) 11/2021 - 08/2014
3	Hyperplasia 10/2021 - 07/2004
3	Autoimmune Polyendocrinopathies (Schmidt Syndrome) 01/2021 - 08/2016
3	COVID-19 01/2021 - 07/2020
3	Melanoma (Melanoma, Malignant) 01/2019 - 08/2012
3	Lipodystrophy 01/2017 - 04/2005
2	Carcinoma (Carcinomatosis) 11/2022 - 01/2019
2	Jaundice (Icterus) 04/2022 - 12/2017
2	Weight Loss (Weight Reduction) 01/2022 - 01/2010
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 03/2017
2	Liver Neoplasms (Liver Cancer) 12/2021 - 10/2010
2	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 12/2019
2	Chronic Hepatitis D 01/2021 - 10/2015

Drug/Important Bio-Agent (IBA)

23	Alanine Transaminase (SGPT)IBA 11/2021 - 02/2004
19	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2003
16	RNA (Ribonucleic Acid)IBA 11/2022 - 07/2003
16	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 01/2003
12	nasIBA 10/2022 - 06/2005
12	Transaminases (Aminotransferases)IBA 04/2022 - 01/2003
11	Pharmaceutical PreparationsIBA 01/2022 - 03/2007
10	Dyphylline (Diprophylline)FDA Link 01/2022 - 06/2011
10	EnzymesIBA 10/2021 - 11/2009
9	DNA (Deoxyribonucleic Acid)IBA 05/2022 - 07/2004
8	Triglycerides (Triacylglycerol)IBA 01/2022 - 04/2005
8	Insulin (Novolin)FDA Link 01/2021 - 01/2004
8	Antiviral Agents (Antivirals)IBA 01/2019 - 08/2006
7	AntigensIBA 06/2022 - 07/2004
7	Hepatitis B Surface Antigens (HBsAg)FDA Link 06/2022 - 10/2009
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2009
6	InterferonsIBA 01/2019 - 02/2003
6	Pioglitazone (Actos)FDA Link 10/2015 - 01/2004
6	Ribavirin (Virazole)FDA LinkGeneric 03/2015 - 07/2003
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 08/2014
5	tesamorelin FDA Link 01/2021 - 12/2019
5	AutoantibodiesIBA 01/2021 - 03/2009
5	Vitamin E FDA LinkGeneric 10/2020 - 01/2009
5	Alkaline PhosphataseIBA 11/2013 - 10/2006
4	LipidsIBA 10/2022 - 07/2011
4	Hepatitis B Core AntigensIBA 06/2022 - 10/2009
4	Biological ProductsIBA 01/2021 - 07/2004
4	Hepatitis B e AntigensIBA 01/2021 - 02/2015
4	IronIBA 11/2017 - 02/2005
4	LeptinIBA 01/2017 - 04/2005
4	Alanine (L-Alanine)FDA Link 09/2010 - 01/2003
3	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2022 - 01/2017
3	CytokinesIBA 11/2021 - 08/2006
3	Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA 01/2021 - 01/2020
3	Immunoglobulin G (IgG)IBA 11/2020 - 06/2008
3	Protons (Proton)IBA 12/2019 - 01/2017
3	Fatty Acids (Saturated Fatty Acids)IBA 03/2016 - 08/2006
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2022 - 10/2021
2	pembrolizumabIBA 11/2022 - 01/2019
2	Lipoproteins (Lipoprotein)IBA 10/2022 - 01/2019
2	Anticonvulsants (Antiepileptic Drugs)IBA 04/2022 - 01/2019
2	TeaIBA 01/2022 - 01/2021
2	Peptidoglycan (Murein)IBA 11/2021 - 07/2019
2	Fluorouracil (Carac)FDA LinkGeneric 10/2021 - 12/2003
2	LipopolysaccharidesIBA 01/2021 - 07/2019
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 12/2019
2	Insulin-Like Growth Factor I (IGF-1)IBA 01/2021 - 07/2006

Therapy/Procedure

52	Therapeutics 05/2022 - 02/2003
18	Liver Transplantation 01/2022 - 02/2010
6	Hematopoietic Stem Cell Transplantation 01/2022 - 03/2007
4	Aftercare (After-Treatment) 12/2021 - 11/2006
4	Bariatric Surgery 12/2021 - 12/2010
3	Highly Active Antiretroviral Therapy (HAART) 01/2021 - 01/2013
3	Transplantation 11/2019 - 01/2013
3	Drug Therapy (Chemotherapy) 01/2017 - 12/2003
2	Immunotherapy 12/2021 - 10/2010
2	Adjuvant Chemotherapy 10/2021 - 10/2021